These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28444232)

  • 1. Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus-Exposed, Uninfected Infants in Malawi: The BAN Study.
    Davis NL; Wiener J; Juliano JJ; Adair L; Chasela CS; Kayira D; Hudgens MG; van der Horst C; Jamieson DJ; Kourtis AP; ;
    Clin Infect Dis; 2017 Aug; 65(4):575-580. PubMed ID: 28444232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.
    Davis NL; Barnett EJ; Miller WC; Dow A; Chasela CS; Hudgens MG; Kayira D; Tegha G; Ellington SR; Kourtis AP; van der Horst C; Jamieson DJ; Juliano JJ
    Clin Infect Dis; 2015 Aug; 61(3):368-74. PubMed ID: 25900173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.
    Ewing AC; King CC; Wiener JB; Chasela CS; Hudgens MG; Kamwendo D; Tegha G; Hosseinipour MC; Jamieson DJ; Van der Horst C; Kourtis AP
    AIDS; 2017 Nov; 31(18):2455-2463. PubMed ID: 28926409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.
    Sandison TG; Homsy J; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Kalamya J; Vora N; Kublin J; Kamya MR; Dorsey G; Tappero JW
    BMJ; 2011 Mar; 342():d1617. PubMed ID: 21454456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
    Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
    Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants.
    Dow A; Kayira D; Hudgens M; Van Rie A; King CC; Ellington S; Kourtis A; Turner AN; Meshnick S; Kacheche Z; Jamieson DJ; Chasela C; van der Horst C
    Pediatr Infect Dis J; 2012 Aug; 31(8):842-7. PubMed ID: 22801093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of anti-retroviral/Trimethoprim-Sulfamethoxazole therapy in a longitudinal cohort of HIV-1 positive individuals in Western Kenya rapidly decreases asymptomatic malarial parasitemia.
    Kifude CM; Roberds A; Oyieko J; Ocholla S; Otieno S; Waitumbi JN; Hutter J; Smith H; Copeland NK; Luckhart S; Stewart VA
    Front Cell Infect Microbiol; 2022; 12():1025944. PubMed ID: 36506016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-trimoxazole prophylaxis for children who are HIV-exposed and uninfected: a systematic review.
    Wedderburn CJ; Evans C; Slogrove AL; Rehman AM; Gibb DM; Prendergast AJ; Penazzato M
    J Int AIDS Soc; 2023 Jun; 26(6):e26079. PubMed ID: 37292018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
    Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
    Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
    Steketee RW; Wirima JJ; Slutsker L; Roberts JM; Khoromana CO; Heymann DL; Breman JG
    Am J Trop Med Hyg; 1996; 55(1 Suppl):24-32. PubMed ID: 8702034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women.
    Dow A; Kayira D; Hudgens MG; Van Rie A; King CC; Ellington S; Chome N; Kourtis A; Turner AN; Kacheche Z; Jamieson DJ; Chasela C; van der Horst C
    Infect Dis Obstet Gynecol; 2013; 2013():340702. PubMed ID: 24363547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria and human immunodeficiency virus infection among male employees of a sugar estate in Malawi.
    Nwanyanwu OC; Kumwenda N; Kazembe PN; Jemu S; Ziba C; Nkhoma WC; Redd SC
    Trans R Soc Trop Med Hyg; 1997; 91(5):567-9. PubMed ID: 9463669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1.
    Steketee RW; Wirima JJ; Bloland PB; Chilima B; Mermin JH; Chitsulo L; Breman JG
    Am J Trop Med Hyg; 1996; 55(1 Suppl):42-9. PubMed ID: 8702036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
    Ottichilo RK; Polyak CS; Guyah B; Singa B; Nyataya J; Yuhas K; John-Stewart G; Waitumbi JN
    J Infect Dis; 2017 Jan; 215(1):88-94. PubMed ID: 28077587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HIV-1 Serostatus on the Prevalence of Asymptomatic Plasmodium falciparum Parasitemia Among Children Less Than 5 Years of Age in Benin City, Nigeria.
    Okonkwo IR; Ibadin MO; Omoigberale AI; Sadoh WE
    J Pediatric Infect Dis Soc; 2016 Mar; 5(1):21-8. PubMed ID: 26908488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting.
    Kakuru A; Natureeba P; Muhindo MK; Clark TD; Havlir DV; Cohan D; Dorsey G; Kamya MR; Ruel T
    Malar J; 2016 Oct; 15(1):500. PubMed ID: 27756308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and the incidence of malaria among HIV-exposed children from Tanzania.
    Ezeamama AE; Spiegelman D; Hertzmark E; Bosch RJ; Manji KP; Duggan C; Kupka R; Lo MW; Okuma JO; Kisenge R; Aboud S; Fawzi WW
    J Infect Dis; 2012 May; 205(10):1486-94. PubMed ID: 22457274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children.
    Kalyesubula I; Musoke-Mudido P; Marum L; Bagenda D; Aceng E; Ndugwa C; Olness K
    Pediatr Infect Dis J; 1997 Sep; 16(9):876-81. PubMed ID: 9306483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between peripheral Plasmodium falciparum malaria parasitemia, human immunodeficiency virus, and concurrent helminthic infection among pregnant women in Malawi.
    Thigpen MC; Filler SJ; Kazembe PN; Parise ME; Macheso A; Campbell CH; Newman RD; Steketee RW; Hamel M
    Am J Trop Med Hyg; 2011 Mar; 84(3):379-85. PubMed ID: 21363973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.